An Integrative Approach to Ketamine Therapy May Enhance Multiple Dimensions of Efficacy: Improving Therapeutic Outcomes With Treatment Resistant Depression
Research over the last two decades has established ketamine as a safe, effective, fast-acting, and sustained antidepressant that significantly reduces adverse symptoms associated with depression, even in patients who are treatment resistant. Much of this research has evolved within the framework of...
Guardado en:
Autores principales: | Sherry-Anne Muscat, Glenn Hartelius, Courtenay Richards Crouch, Kevin W. Morin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a499c78a4b10447d8cf867dd4fa082f1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Immunoregulation and antidepressant effect of ketamine
por: Zhang Nan, et al.
Publicado: (2021) -
Case Report: Unexpected Remission From Extreme and Enduring Bulimia Nervosa With Repeated Ketamine Assisted Psychotherapy
por: Anya Ragnhildstveit, et al.
Publicado: (2021) -
Procedural moderate sedation with ketamine in pediatric critical care unit
por: Tarek R Hazwani, et al.
Publicado: (2017) -
Ketamine—New Possibilities in the Treatment of Depression: A Narrative Review
por: Mateusz Kowalczyk, et al.
Publicado: (2021) -
Deficits in N-Methyl-D-Aspartate Receptor Function and Synaptic Plasticity in Hippocampal CA1 in APP/PS1 Mouse Model of Alzheimer’s Disease
por: Le Xu, et al.
Publicado: (2021)